Purpose
We sought to determine the effectiveness of corticosteroid injections (CSIs) for de
Quervain tenosynovitis in patients with diabetes mellitus.
Methods
We retrospectively identified all patients with diabetes receiving a CSI for de Quervain
tenosynovitis by 16 surgeons over a 2-year period. Data collected included demographic
information, medical comorbidities, number and timing of CSIs, and first dorsal compartment
release. Success was defined as not undergoing an additional CSI or surgical intervention.
The mixture of a corticosteroid and local anesthetic provided in each injection was
at the discretion of each individual surgeon.
Results
Corticosteroid injections were given to 169 wrists in 169 patients with diabetes.
Out of 169 patients, 83 (49%) had success following the initial CSI, 44 (66%) following
a second CSI, and 6 (67%) following a third CSI. A statistically significant difference
was identified in the success rates between the first and second CSIs. Ultimately,
36 of 169 wrists (21%) underwent a first dorsal compartment release.
Conclusions
Patients with diabetes mellitus have a decreased probability of success following
a single CSI for de Quervain tenosynovitis in comparison to nondiabetic patients,
as described in the literature. However, the effectiveness of each additional CSI
does not appear to diminish.
Type of study/level of evidence
Therapeutic IV.
Key words
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Hand SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- De Quervain tendinopathy: survivorship and prognostic indicators of recurrence following a single corticosteroid injection.J Hand Surg Am. 2015; 40: 1161-1165
- Tenosynovitis of the hand and wrist: a critical analysis review.JBJS Rev. 2016; 4: e7
- Effect of local corticosteroid injection of the hand and wrist on blood glucose in patients with diabetes mellitus.Orthopedics. 2012; 35: e1754-e1758
- Nonsurgical treatment for de Quervain’s tenosynovitis.J Hand Surg Am. 2009; 34: 928-929
- De Quervain tenosynovitis: an evaluation of the epidemiology and utility of multiple injections using a national database.J Hand Surg Am. 2022; 47: 284.e1-284.e6
- Long-term effectiveness of repeat corticosteroid injections for trigger finger.J Hand Surg Am. 2017; 42: 227-235
- Diabetic hands: a study on strength and function.Diabetes Metab Syndr. 2014; 8: 162-165
- Current treatment of de Quervain tendinopathy.J Hand Surg Am. 2013; 38 (quiz 2250): 2247-2249
- Treatment of de Quervain’s disease.J Hand Surg Am. 1994; 19: 595-598
- De Quervain’s disease: surgical or nonsurgical treatment.J Hand Surg Am. 1990; 15: 83-87
- Treatment of de Quervain’s disease: role of conservative management.J Hand Surg Br. 2001; 26: 258-260
- Corticosteroid injection in diabetic patients with trigger finger. A prospective, randomized, controlled double-blinded study.J Bone Joint Surg Am. 2007; 89: 2604-2611
- Outcome of trigger finger treatment in diabetes.J Diabetes Complications. 1997; 11: 287-290
- Effectiveness of corticosteroid injections for treatment of de Quervain’s tenosynovitis.Hand (N Y). 2017; 12: 357-361
Article info
Publication history
Published online: May 06, 2022
Accepted:
February 16,
2022
Received:
May 26,
2021
Footnotes
No benefits in any form have been received or will be received related directly or indirectly to the subject of this article.
Identification
Copyright
© 2022 by the American Society for Surgery of the Hand. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Journal CME QuestionsJournal of Hand SurgeryVol. 47Issue 10
